Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis

We have reported previously that dihydropyridine-type calcium-channel antagonists (DTCCA) such as nifedipine decrease plasma markers of oxidative stress damage in systemic sclerosis (SSc). To clarify the cellular basis of these beneficial effects, we investigated the effects in vivo and in vitro of...

Descripción completa

Detalles Bibliográficos
Autores principales: Allanore, Yannick, Borderie, Didier, Périanin, Axel, Lemaréchal, Hervé, Ekindjian, Ohvanesse Garabed, Kahan, André
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064885/
https://www.ncbi.nlm.nih.gov/pubmed/15642147
http://dx.doi.org/10.1186/ar1457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064885/
https://www.ncbi.nlm.nih.gov/pubmed/15642147
http://dx.doi.org/10.1186/ar1457

Ejemplares similares